{
  "trial_id": "NCT02790437",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, body mass index (BMI), duration of kidney failure, previous desensitization attempts, type of donor (live or deceased), baseline Donor Specific Antibodies (DSAs) levels, baseline crossmatch test result, comorbid conditions (e.g., diabetes, hypertension), previous treatments (e.g., IVIg), baseline kidney function (e.g., serum creatinine, eGFR), Hgb levels, HIV status, HBV status, HCV status, tuberculosis status, CMV status, EBV status, history of thrombotic events, cardiovascular status (e.g., NYHA grade), pulmonary status (e.g., COPD status), use of investigational drugs, allergy/sensitivity to IdeS.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Weight",
          "body mass index (BMI)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "duration of kidney failure",
        "previous desensitization attempts",
        "type of donor (live or deceased)",
        "baseline Donor Specific Antibodies (DSAs) levels",
        "baseline crossmatch test result",
        "comorbid conditions (e.g., diabetes, hypertension)",
        "previous treatments (e.g., IVIg)",
        "baseline kidney function (e.g., serum creatinine, eGFR)",
        "Hgb levels",
        "HIV status",
        "HBV status",
        "HCV status",
        "tuberculosis status",
        "CMV status",
        "EBV status",
        "history of thrombotic events",
        "cardiovascular status (e.g., NYHA grade)",
        "pulmonary status (e.g., COPD status)",
        "use of investigational drugs",
        "allergy/sensitivity to IdeS"
      ]
    },
    "processed-gen-response": "Age, gender, race, body mass index (BMI), duration of kidney failure, previous desensitization attempts, type of donor (live or deceased), baseline Donor Specific Antibodies (DSAs) levels, baseline crossmatch test result, comorbid conditions (e.g., diabetes, hypertension), previous treatments (e.g., IVIg), baseline kidney function (e.g., serum creatinine, eGFR), Hgb levels, HIV status, HBV status, HCV status, tuberculosis status, CMV status, EBV status, history of thrombotic events, cardiovascular status (e.g., NYHA grade), pulmonary status (e.g., COPD status), use of investigational drugs, allergy/sensitivity to IdeS."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Previous desensitization attempts, Donor Specific Antibodies (DSAs) levels, Crossmatch test results, Kidney transplant waitlist duration, Hgb levels, Co-morbid conditions (e.g., cardiac failure, coronary disease, COPD), HIV status, HBV/HCV status, CMV/EBV status,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Previous desensitization attempts",
        "Donor Specific Antibodies (DSAs) levels",
        "Crossmatch test results",
        "Kidney transplant waitlist duration",
        "Hgb levels",
        "Co-morbid conditions (e.g., cardiac failure, coronary disease, COPD)",
        "HIV status",
        "HBV/HCV status",
        "CMV/EBV status"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Previous desensitization attempts, Donor Specific Antibodies (DSAs) levels, Crossmatch test results, Kidney transplant waitlist duration, Hgb levels, Co-morbid conditions (e.g., cardiac failure, coronary disease, COPD), HIV status, HBV/HCV status, CMV/EBV status"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Gender, Ethnicity (NIH/OMB), Region of Enrollment, Previous kidney transplant, Donor type (deceased or live), Crossmatch test result, Panel reactive antibody (PRA) level, Donor specific antibodies (DSAs) level,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Race/Ethnicity",
          "Ethnicity (NIH/OMB)"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Previous kidney transplant",
        "Donor type (deceased or live)",
        "Crossmatch test result",
        "Panel reactive antibody (PRA) level",
        "Donor specific antibodies (DSAs) level"
      ]
    },
    "processed-gen-response": "Age, Gender, Ethnicity (NIH/OMB), Region of Enrollment, Previous kidney transplant, Donor type (deceased or live), Crossmatch test result, Panel reactive antibody (PRA) level, Donor specific antibodies (DSAs) level"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), kidney disease etiology, duration of kidney disease, previous desensitization attempts, number of human leukocyte antigen (HLA) mismatches, panel reactive antibody (PRA) level, donor-specific antibody (DSA) level, crossmatch test results, serum creatinine level, estimated glomerular filtration rate (eGFR), hemoglobin level, comorbidities (e.g., diabetes, hypertension, cardiovascular disease), concomitant medications, New York Heart Association (NYHA) grade, forced expiratory volume (FEV1) percentage predicted.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Weight",
          "weight"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "height",
        "body mass index (BMI)",
        "kidney disease etiology",
        "duration of kidney disease",
        "previous desensitization attempts",
        "number of human leukocyte antigen (HLA) mismatches",
        "panel reactive antibody (PRA) level",
        "donor-specific antibody (DSA) level",
        "crossmatch test results",
        "serum creatinine level",
        "estimated glomerular filtration rate (eGFR)",
        "hemoglobin level",
        "comorbidities (e.g., diabetes, hypertension, cardiovascular disease)",
        "concomitant medications",
        "New York Heart Association (NYHA) grade",
        "forced expiratory volume (FEV1) percentage predicted"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), kidney disease etiology, duration of kidney disease, previous desensitization attempts, number of human leukocyte antigen (HLA) mismatches, panel reactive antibody (PRA) level, donor-specific antibody (DSA) level, crossmatch test results, serum creatinine level, estimated glomerular filtration rate (eGFR), hemoglobin level, comorbidities (e.g., diabetes, hypertension, cardiovascular disease), concomitant medications, New York Heart Association (NYHA) grade, forced expiratory volume (FEV1) percentage predicted."
  }
}